Hepatotoxicity of silica nanoparticles with a diameter of 100nm

Pharmazie

Volumn 66, Issue 9, 2011, Pages 698-703

  Hasezaki, T ^a   Isoda, K ^a   Kondoh, M ^a   Tsutsumi, Y ^a,b   Yagi, Kiyohito ^a  

^a OSAKA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; NANOPARTICLE; SILICON NANOPARTICLE; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; LIVER SINUSOID; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; PARTICLE SIZE;

ALANINE TRANSAMINASE; ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; CONTRAST MEDIA; CYCLOPHOSPHAMIDE; DRUG-INDUCED LIVER INJURY; GADOLINIUM; HEPATOCYTES; HERBICIDES; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER FUNCTION TESTS; MALE; MICE; MICE, INBRED BALB C; NANOPARTICLES; PARAQUAT; PARTICLE SIZE; SILICON DIOXIDE;

EID: 84055194027     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2011.1516     Document Type: Article

References (28)

1. Bystrzejewska-Piotrowska G., Golimowski J, Urban PL (2009) Nanoparticles: their potential toxicity,waste and environmental management.Waste Manag 29: 2587-2595.
2. Chung EA, Koo J, Lee M, Jeong DY, Kim S (2009) Enhancement-mode silicon nanowire field-effect transistors on plastic substrates. Small 5: 1821-1824.
3. DeLeve LD (1996) Cellular target of cyclophosphamide toxicity in the murine liver: role of glutathione and site of metabolic activation. Hepatology 24: 830-837.
4. Hardonk MJ, Dijkhuis FW, Hulstaert CE, Koudstaal J (1992) Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and repopulation. J Leukoc Biol 52: 296-302.
5. Kobler J, Bein T (2008) Porous thin films of functionalized mesoporous silica nanoparticles. ACS Nano 2: 2324-2330.
6. Malhi H, Annamaneni P, Slehria S, Joseph B, Bhargava KK, Palestro CJ, Novikoff PM, Gupta S (2002) Cyclophosphamide disrupts hepatic sinusoidal endothelium and improves transplanted cell engraftment in rat liver. Hepatology 36: 112-121. (Pubitemid 34700768)
7. Martin, KR (2007) The chemistry of silica and its potential health benefits. J Nutr Health Aging 11: 94-97.
8. McNally L, O'Sullivan DJ, Jagger DC (2006) An in vitro investigation of the effect of the addition of untreated and surface treated silica on the transverse and impact strength of poly(methyl methacrylate) acrylic resin. Biomed Mater Eng 16: 93-100. (Pubitemid 43221075)
9. McCuskey RS (2008) The hepatic microvascular system in health and its response to toxicants. Anat Rec (Hoboken) 291: 661-671.
10. Merget R, Bauer T, Kupper HU, Philippou S, Bauer HD, Breitstadt R, Bruening T (2002) Health hazards due to the inhalation of amorphous silica. Arch Toxicol 75: 625-634. (Pubitemid 34151149)
11. Moreno D, Zalba S, Navarro I, Tros de Ilarduya C, Garrido MJ (2009) Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice. Eur J Pharm Biopharm 74: 265-274.
12. Nishimori H, Kondoh M, Isoda K, Tsunoda S, Tsutsumi Y, Yagi K (2009a) Histological analysis of 70-nm silica particles-induced chronic toxicity in mice. Eur J Pharm Biopharm 72: 626-629.
13. Nishimori H, Kondoh M, Isoda K, Tsunoda S, Tsutsumi Y, Yagi K (2009b) Influence of 70 nm silica particles in mice with cisplatin or paraquatinduced toxicity. Pharmazie 64: 395-397.
14. Nishimori H, Kondoh M, Isoda K, Tsunoda S, Tsutsumi Y, Yagi K (2009c) Silica nanoparticles as hepatotoxicants. Eur J Pharm Biopharm 72: 496-501.
15. Ozols RF, Young RC (1991) Chemotherapy of ovarian cancer. Semin Oncol 18: 222-232.
16. Seglen PO (1976) Preparation of isolated rat liver cells. Methods Cell Biol 13: 29-83.
17. Shavandi Z, Ghazanfari T, Moghaddam KN (2010) In vitro toxicity of silver nanoparticles on murine peritoneal macrophages. Immunopharmacol Immunotoxicol. 27.
18. Smedsrod B, Melkko J, Araki N, Sano H, Horiuchi S (1997) Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells. Biochem J 322 (Pt 2): 567-573. (Pubitemid 27116585)
19. Steffan AM, Gendrault JL, McCuskey RS, McCuskey PA, Kirn A (1986) Phagocytosis, an unrecognized property of murine endothelial liver cells. Hepatology 6: 830-836. (Pubitemid 16006734)
20. Stone V, Johnston H, Clift MJ (2007) Air pollution, ultrafine and nanoparticle toxicology: cellular and molecular interactions. IEEE Trans Nanobioscience 6: 331-340. (Pubitemid 350210539)
21. Tsuda H, Xu J, Sakai Y, Futakuchi M, Fukamachi K (2009) Toxicology of engineered nanomaterials - a review of carcinogenic potential. Asian Pac J Cancer Prev 10: 975-980.
22. Vamanu CI, Cimpan MR, Hol PJ, Sornes S, Lie SA, Gjerdet NR (2008) Induction of cell death by TiO2 nanoparticles: studies on a human monoblastoid cell line. Toxicol In Vitro 22: 1689-1696.
23. van Til NP, Markusic DM, van der Rijt R, Kunne C, Hiralall JK, Vreeling H, Frederiks WM, Oude-Elferink RP, Seppen J (2005) Kupffer cells and not liver sinusoidal endothelial cells prevent lentiviral transduction of hepatocytes. Mol Ther 11: 26-34. (Pubitemid 40011996)
24. Vandenbogaerde J, Schelstraete J, Colardyn F, Heyndrickx A (1984) Paraquat poisoning. Forensic Sci Int 26: 103-114. (Pubitemid 14011972)
25. Verma AK, Sachin K (2008) Novel hydrophilic drug polymer nanoconjugates of Cisplatin showing long blood retention profile: its releasekinetics, cellular uptake and bio-distribution. Curr Drug Deliv 5: 120-126. (Pubitemid 351536318)
26. Warheit DB, Sayes CM, Reed KL,Swain KA (2008) Health effects related to nanoparticle exposures: environmental, health and safety considerations for assessing hazards and risks. Pharmacol Ther 120: 35-42.
27. Wisse E, Braet F, Luo D, De Zanger R, Jans D, Crabbe E, Vermoesen A (1996) Structure and function of sinusoidal lining cells in the liver. Toxicol Pathol 24: 100-111. (Pubitemid 26066425)
28. Witjes JA (1997) Current recommendations for the management of bladder cancer. Drug therapy. Drugs 53: 404-414.